• Home >
  • Vital Signs - Over the Patent Cliff: Suing the FDA is the Latest Action by Branded and Generics Pharmaceutical Companies Battling for Market Opportunity

Vital Signs - Over the Patent Cliff: Suing the FDA is the Latest Action by Branded and Generics Pharmaceutical Companies Battling for Market Opportunity

07-Mar-2013  /  Research Code: 9561-00-F3-00-00  /  SKU: LS00245-NA-MR_17659  /  
Region: North America

USD 1,500.00

* Required Fields

USD 1,500.00

PAY BY INVOICE

Be the first to review this product

This issue of Vital Signs, released on March 7, 2013, provides an insight in to battle between FDA and branded and generic pharmaceutical companies. Additionally, a company spotlight is provided for PLC Diagnostics. PLC Diagnostics is an early stage startup, developing the next generation of handheld point-of-care testing devices.

Table of Contents

Vital Signs - Over the Patent Cliff: Suing the FDA is the Latest Action by Branded and Generics Pharmaceutical Companies Battling for Market OpportunityVital Signs: 7 March 2013This week's issue




Related Research

Analysis of the Singapore Clinical Laboratories Market, Forecast to 2021

Release Date : 12-Nov-18

Region : Asia Pacific

US Medical Marijuana Market, Forecast to 2022

Release Date : 18-Jul-18

Region : Global

Why Now is The Time for Interoperable Healthcare Solutions?

Release Date : 05-Jul-18

Region : Global

Growth Insights for European Infectious Disease Point-of-Care Testing (POCT) Market, Forecast to 2022

Release Date : 25-Jun-18

Region : Europe

Global Pharma Clinical Trial Patient Recruitment & Monitoring IT Solutions, Forecast to 2020

Release Date : 17-May-18

Region : North America

Growth Insights on the US Therapeutic Apheresis Market, Forecast to 2021

Release Date : 07-Nov-17

Region : North America

Growth and Investment Opportunities in Nepal Healthcare Market, 2017

Release Date : 06-Nov-17

Region : South Asia, Middle East & North Africa

Growth Insights on the Global CRISPR/Cas9 Tools Market, 2017

Release Date : 31-Oct-17

Region : North America

Global Digital Pathology Market, 2017 Companies-To-Action

Release Date : 31-Oct-17

Region : Global

Growth Opportunities in the Western European Oncology Diagnostics Market, Forecast to 2021

Release Date : 30-Jun-17

Region : Europe

Why Frost & Sullivan

Vision & Strategy

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Brand & Demand

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Technology & IP

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

Global Prespective

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.